Surgery Partners, Inc.
SGRY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,670 | $4,018 | $2,562 | $3,868 |
| - Cash | $270 | $196 | $283 | $390 |
| + Debt | $3,703 | $3,062 | $2,930 | $3,295 |
| Enterprise Value | $6,104 | $6,884 | $5,209 | $6,773 |
| Revenue | $3,114 | $2,743 | $2,539 | $2,225 |
| % Growth | 13.5% | 8% | 14.1% | – |
| Gross Profit | $746 | $648 | $575 | $491 |
| % Margin | 23.9% | 23.6% | 22.6% | 22.1% |
| EBITDA | $501 | $446 | $460 | $401 |
| % Margin | 16.1% | 16.3% | 18.1% | 18% |
| Net Income | -$168 | -$12 | -$55 | -$71 |
| % Margin | -5.4% | -0.4% | -2.2% | -3.2% |
| EPS Diluted | -1.33 | -0.095 | -0.59 | -1.12 |
| % Growth | -1,304.4% | 83.9% | 47.3% | – |
| Operating Cash Flow | $300 | $294 | $159 | $87 |
| Capital Expenditures | -$90 | -$89 | -$81 | -$58 |
| Free Cash Flow | $210 | $205 | $78 | $30 |